Why Should You Choose AVONEX® (interferon beta-1a)?

Why AVONEX?

Help slow physical disability progression and reduce flare-ups

When you're first diagnosed with relapsing multiple sclerosis (relapsing MS), you may be worried about disability progression and what that might mean. But you should know AVONEX is FDA approved to delay the progression of physical disability.

In a 2-year clinical study, it took significantly longer for people taking AVONEX to have increased physical disability compared with people who weren't treating their MS. In fact, people taking AVONEX were 37% less likely to have increased physical disability at 2 years.

At the end of this study, 78% of people taking AVONEX had no increase in physical disability, compared with around 65% of people who weren't treating their relapsing MS.

Nearly 8 out of 10 people taking AVONEX
had no increase in physical disability

Most people who take AVONEX have flu-like symptoms early during the course of therapy. Usually, these symptoms last for a day after the injection. You may be able to manage these flu-like symptoms by taking over-the-counter pain and fever reducers. For many people, these symptoms lessen or go away over time. Symptoms may include muscle aches, fever, tiredness, and chills.

  • Live your life with fewer flare-ups
  • For most people, flare-ups are some of the most noticeable signs of relapsing MS. They're unpredictable and can cause damage to the central nervous system (CNS). So it's important to work with your healthcare provider to consider a treatment option that can help reduce flare-ups.

    Avonex reduced flare-ups by 32% AVONEX reduces flare-ups: In people who took AVONEX for the full 2 years of a study, AVONEX reduced flare-ups by 32% compared with people who weren't treating their relapsing MS.

    When including the people enrolled in the study who didn't take AVONEX for the full 2 years, AVONEX reduced flare-ups by 18% compared with people who weren't treating their relapsing MS.

    AVONEX will not cure your MS but may decrease the number of flare-ups of the disease and slow the occurrence of some of the physical disability that is common in people with MS.

  • Early treatment matters
  • Many experts agree that treatment should start as soon as possible, because relapsing MS can progress even if you don't have any observed symptoms.

    In a study of people who had only experienced one flare-up,* people taking AVONEX were 44% less likely to have a second flare-up at 3 years, compared with people who weren't treating their relapsing MS.

    AVONEX is FDA approved to work even if you've had one flare-up.

  • Dosing that fits your schedule
  • AVONEX is a once-a-week treatment for relapsing MS. Think about whether a once-a-week treatment might fit your schedule.


AVONEX PEN:
A Simple Switch

Currently using AVONEX Prefilled Syringe, but want to try AVONEX PEN? Learn about making the switch.

Download PDF

Considering AVONEX? Get your first month FREE*

If you and your healthcare provider are considering starting treatment with AVONEX, sign up for the AVONEX First Month Free Trial Program to try it free for one month.

Sign up now

Neurologist Discussion Guide

Download this guide now and have a discussion with your healthcare provider to learn more about treating your relapsing MS.

Download PDF

Find out more about using
the once-a week AVONEX PEN.

* A study of people who had experienced a first attack and had lesions consistent with MS on their MRIs. In this study a second flare-up was defined as 1) a new clinical sign of MS that differed from the patient's presentation when they entered the study or 2) an increase of at least 1.5 EDSS points or 3) further worsening noted at 2 months or the patient withdrew before completing two months of treatment.

Depending on your income or, in some cases, if your medication is obtained from an out-of-network provider, there may be an annual cap that limits the amount of assistance that you can receive over one year.

Open Close

Important Safety Information and Indication

AVONEX can cause serious side effects. Tell your healthcare provider right away if you have any of the symptoms listed below while taking AVONEX.

Indication

AVONEX (interferon beta-1a) is approved by FDA to treat relapsing forms of multiple sclerosis (MS) to decrease the number of flare-ups and slow the occurrence of some of the physical disability that is common in people with MS. AVONEX is approved for use in people who have experienced a first attack and have lesions consistent with MS on their MRI.

Important Safety Information

Before beginning treatment, you should discuss with your healthcare provider the potential benefits and risks associated with AVONEX.

AVONEX can cause serious side effects. Tell your healthcare provider right away if you have any of the symptoms listed below while taking AVONEX.

AVONEX will not cure your MS but may decrease the number of flare-ups of the disease and slow the occurrence of some of the physical disability that is common in people with MS. MS is a life-long disease that affects your nervous system by destroying the protective covering (myelin) that surrounds your nerve fibers.

The way AVONEX works in MS is not known. It is not known if AVONEX is safe and effective in children.

Do not take AVONEX if you are allergic to interferon beta, albumin (human), or any of the ingredients in AVONEX.

Before taking AVONEX, tell your healthcare provider if you:

Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.

AVONEX can cause serious side effects including:

Tell your healthcare provider right away if you have any of the symptoms listed above.

The most common side effects of AVONEX include:

Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see the full Prescribing Information and Medication Guide for additional important safety information. This information is not intended to replace discussions with your healthcare provider.

Indication

AVONEX (interferon beta-1a) is approved by FDA to treat relapsing forms of multiple sclerosis (MS) to decrease the number of flare-ups and slow the occurrence of some of the physical disability that is common in people with MS. AVONEX is approved for use in people who have experienced a first attack and have lesions consistent with MS on their MRI.